Motley Fool Asset Management LLC Has $878,000 Stake in Certara, Inc. (NASDAQ:CERT)

Motley Fool Asset Management LLC lifted its position in shares of Certara, Inc. (NASDAQ:CERT) by 8.7% during the fourth quarter, Holdings Channel.com reports. The firm owned 49,895 shares of the company’s stock after purchasing an additional 4,005 shares during the period. Motley Fool Asset Management LLC’s holdings in Certara were worth $878,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of CERT. Covestor Ltd raised its position in Certara by 14,940.0% in the 3rd quarter. Covestor Ltd now owns 3,760 shares of the company’s stock valued at $55,000 after buying an additional 3,735 shares during the last quarter. Gamco Investors INC. ET AL purchased a new stake in shares of Certara during the 3rd quarter valued at $145,000. NorthRock Partners LLC purchased a new stake in shares of Certara during the 3rd quarter valued at $168,000. Natixis Advisors L.P. increased its position in shares of Certara by 13.4% during the 3rd quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock valued at $220,000 after purchasing an additional 1,791 shares during the last quarter. Finally, Pacer Advisors Inc. increased its position in shares of Certara by 1,704.0% during the 4th quarter. Pacer Advisors Inc. now owns 12,754 shares of the company’s stock valued at $224,000 after purchasing an additional 12,047 shares during the last quarter. 73.96% of the stock is owned by institutional investors and hedge funds.

Certara Trading Up 1.7 %

CERT stock traded up $0.27 during midday trading on Friday, hitting $16.57. The company had a trading volume of 321,643 shares, compared to its average volume of 533,272. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.28. Certara, Inc. has a 52 week low of $11.81 and a 52 week high of $24.64. The stock’s 50 day moving average price is $17.69 and its 200 day moving average price is $16.24. The stock has a market cap of $2.65 billion, a price-to-earnings ratio of -47.34, a PEG ratio of 1.70 and a beta of 1.63.

Certara (NASDAQ:CERT) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. The company had revenue of $88.01 million during the quarter, compared to the consensus estimate of $86.80 million. As a group, equities research analysts expect that Certara, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Buying and Selling at Certara

In other news, SVP Richard M. Traynor sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the transaction, the senior vice president now directly owns 173,524 shares of the company’s stock, valued at $3,123,432. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total value of $243,094.95. Following the sale, the insider now directly owns 50,091 shares of the company’s stock, valued at $844,033.35. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Richard M. Traynor sold 3,000 shares of the business’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $18.00, for a total value of $54,000.00. Following the completion of the sale, the senior vice president now directly owns 173,524 shares in the company, valued at $3,123,432. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 23,427 shares of company stock worth $405,095. 2.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on CERT shares. KeyCorp raised Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective for the company in a report on Wednesday, April 10th. UBS Group lifted their target price on Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a report on Friday, March 1st. Jefferies Financial Group lifted their target price on Certara from $14.00 to $15.50 and gave the company a “hold” rating in a report on Friday, March 1st. Barclays lifted their target price on Certara from $16.00 to $18.00 and gave the company an “equal weight” rating in a report on Thursday, January 25th. Finally, SVB Leerink started coverage on Certara in a report on Monday, February 26th. They set a “market perform” rating and a $19.00 target price for the company. Seven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $20.06.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.